TY - JOUR
T1 - The Role of Hypertension in Race-Ethnic Disparities in Cardiovascular Disease
AU - Balfour, Pelbreton C.
AU - Rodriguez, Carlos J.
AU - Ferdinand, Keith C.
N1 - Funding Information:
Pelbreton Balfour, Jr. has no relevant disclosures. Keith Ferdinand has been a consultant for Astra Zeneca, Sanofi, Amgen, Novartis, Forest, Boehinger and Ingleheim. Carlos J. Rodriguez has received grants from the NIH/NHLBI. Rodriguez received consulting payments from Amgen, Alnylam, and the American Heart Association.
Publisher Copyright:
© 2015, Springer Science+Business Media New York.
PY - 2015/4
Y1 - 2015/4
N2 - Race-ethnic disparities in cardiovascular disease (CVD) have persisted in the USA over the past few decades. Hypertension (HTN) is a significant contributor to CVD, including coronary heart disease, stroke, end-stage kidney disease and overall mortality and race-ethnic disparities in longevity. Additionally, both non-Hispanic blacks (NHBs) and Hispanic adults have been known to have higher prevalence of poorly controlled blood pressure compared to non-Hispanic whites (NHWs). Addressing these disparities has been a focus of programs such as the Million Hearts initiative. This review will provide an update of available data on HTN in various race-ethnic groups, including awareness, treatment, and control and note the recent progress in HTN control across all race/ethnic groups. We will also discuss the recent 2014 U.S. HTN guideline that has led to debate regarding the potential impact of BP goals in older persons on worsening CVD disparities, with disproportionate effects on women and NHBs.
AB - Race-ethnic disparities in cardiovascular disease (CVD) have persisted in the USA over the past few decades. Hypertension (HTN) is a significant contributor to CVD, including coronary heart disease, stroke, end-stage kidney disease and overall mortality and race-ethnic disparities in longevity. Additionally, both non-Hispanic blacks (NHBs) and Hispanic adults have been known to have higher prevalence of poorly controlled blood pressure compared to non-Hispanic whites (NHWs). Addressing these disparities has been a focus of programs such as the Million Hearts initiative. This review will provide an update of available data on HTN in various race-ethnic groups, including awareness, treatment, and control and note the recent progress in HTN control across all race/ethnic groups. We will also discuss the recent 2014 U.S. HTN guideline that has led to debate regarding the potential impact of BP goals in older persons on worsening CVD disparities, with disproportionate effects on women and NHBs.
KW - Cardiovascular disease
KW - Ethnicity
KW - Health disparities
KW - High blood pressure
KW - Hypertension
KW - Race
UR - http://www.scopus.com/inward/record.url?scp=84923844234&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923844234&partnerID=8YFLogxK
U2 - 10.1007/s12170-015-0446-5
DO - 10.1007/s12170-015-0446-5
M3 - Review article
AN - SCOPUS:84923844234
SN - 1932-9520
VL - 9
JO - Current Cardiovascular Risk Reports
JF - Current Cardiovascular Risk Reports
IS - 4
ER -
